Erysipelothrix rhusiopathiae knee prosthesis infection

Med Mal Infect. 2018 Aug;48(5):372-373. doi: 10.1016/j.medmal.2018.02.002. Epub 2018 Apr 13.

Authors

P Gazeau¹, S Rezig², L Quaesaet², T Williams³, D Tande⁴, S Ansart²

Affiliations

¹ Service de maladies infectieuses, hôpital de la Cavale-Blanche, BP 824, 29609 Brest cedex, France. Electronic address: pierre.gazeau@chu-brest.fr.
² Service de maladies infectieuses, hôpital de la Cavale-Blanche, BP 824, 29609 Brest cedex, France.
³ Service d'orthopédie, hôpital de la Cavale-Blanche, BP 824, 29609 Brest cedex, France.
⁴ Service de microbiologie, hôpital de la Cavale-Blanche, BP 824, 29609 Brest cedex, France.

PMID: 29656843
DOI: 10.1016/j.medmal.2018.02.002

No abstract available

Keywords: Erysipelothrix rhusiopathiae; Fluoroquinolone; Knee prosthesis; Prothèse de genou.

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Amoxicillin / adverse effects
Amoxicillin / therapeutic use
Arthroplasty, Replacement, Knee
Ceftriaxone / therapeutic use
Chemical and Drug Induced Liver Injury / etiology
Drug Substitution
Erysipelothrix / isolation & purification*
Erysipelothrix Infections / etiology*
Erysipelothrix Infections / microbiology
Humans
Knee Prosthesis / adverse effects*
Knee Prosthesis / microbiology
Levofloxacin / therapeutic use
Male
Prosthesis-Related Infections / etiology*
Prosthesis-Related Infections / microbiology
Recurrence
Reoperation
Sepsis / etiology

Substances

Levofloxacin
Ceftriaxone
Amoxicillin